ClearPoint Neuro, Inc. — Director's Dealing 2026

Feb 19, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2026-02-17

Reporting Person: D'Alessandro Danilo (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-17	Restricted Stock Units	$	A	66273	Acquired		Common Stock (66273)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

F2: The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029.